logo
Book a meeting
iCell Gene Therapeutics

I Cell Gene Therapeutics

Biotechnology, 25 Health Sciences Dr, Stony Brook, New York, 11790, United States, 11-50 Employees

icellgene.com/index.html

  • LinkedIn

phone no Phone Number: 63********

Who is ICELL GENE THERAPEUTICS

iCell Gene Therapeutics is developing Chimeric Antigen Receptor (CAR) engineered cells with improved functional properties and expanded applicability. We are a clinical stage company focu...

Read More

lock icon Get Full Access
map
  • 25 Health Sciences Dr, Stony Brook, New York, 11790, United States Headquarters: 25 Health Sciences Dr, Stony Brook, New York, 11790, United States
  • 2014 Date Founded: 2014
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from ICELL GENE THERAPEUTICS

iCell Gene Therapeutics Org Chart and Mapping

Employees
Yupo Ma

Yupo Ma

Chairman of the Board

See Full Org Chart arrow
email-formate-icon
View Email Formats for iCell Gene Therapeutics
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding ICell Gene Therapeutics

Answer: iCell Gene Therapeutics's headquarters are located at 25 Health Sciences Dr, Stony Brook, New York, 11790, United States

Answer: iCell Gene Therapeutics's phone number is 63********

Answer: iCell Gene Therapeutics's official website is https://icellgene.com/index.html

Answer: iCell Gene Therapeutics's revenue is Under $1 Million

Answer: iCell Gene Therapeutics's SIC: 8731

Answer: iCell Gene Therapeutics has 11-50 employees

Answer: iCell Gene Therapeutics is in Biotechnology

Answer: iCell Gene Therapeutics contact info: Phone number: 63******** Website: https://icellgene.com/index.html

Answer: iCell Gene Therapeutics is developing Chimeric Antigen Receptor (CAR) engineered cells with improved functional properties and expanded applicability. We are a clinical stage company focused to demonstrate clinical proof of concept for unique, patent protected, targets and strategies. Our pipeline includes multiple additional first in man CAR strategies to target hematological cancers, non-hematological cancers and autoimmune disorders.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access